Editas Medicine, Inc.
EDIT· Nasdaq
EDITEditas Medicine, Inc.
Filed Mar 3, 2017 · 10-K · 62 days after period end · 0001558370-17-001340
| Metric | Q4 2016 | Q4 2015 |
|---|---|---|
| Net Income | -$39.38M | -$12.63M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 3, 2017 · 62 d after period end
